Stapleton v. Janssen Pharmaceuticals, Inc
Stapleton v. Janssen Pharmaceuticals, Inc is a federal product liability lawsuit filed on 02/21/2017 in the District Court, D. New Jersey. The case was terminated on 08/24/2020.
A lawsuit records allegations and procedural activity. Being named as a party does not establish liability, wrongdoing, or the merits of any claim.
- Court
- District Court, D. New Jersey (D.N.J.)
Official Court Website → - Assigned judge
- Brian R. Martinotti · 3,168 cases in index
- Docket number
- 3:17-cv-01189
- Nature of suit
- 367 Health care / pharm
Injury from a drug, medical device, or health-care product — often grouped into mass-tort litigation. - Jurisdiction
- Diversity of citizenship
- Date filed
- 02/21/2017
- Date terminated
- 08/24/2020
51,680 Product Liability cases in this court are indexed here.
Parties
- plaintiff · Stapleton · 258 cases
- defendant · Janssen Pharmaceuticals, Inc · 1751 cases
Other Cases Naming This Defendant
Janssen Pharmaceuticals, Inc is named in 1,751 federal civil cases in this index. Recent Product Liability cases naming the same defendant:
About Product Liability Lawsuits
Product liability lawsuits claim that a defective or dangerous product caused injury or harm. These often target manufacturers of drugs, medical devices, vehicles, or consumer goods, and are frequently grouped into mass-tort or multidistrict litigation when many people are affected by the same product.
Frequently Asked Questions
What is Stapleton v. Janssen Pharmaceuticals, Inc?
Stapleton v. Janssen Pharmaceuticals, Inc is a federal product liability lawsuit filed on 02/21/2017 in the District Court, D. New Jersey. The case was terminated on 08/24/2020. Product liability lawsuits claim that a defective or dangerous product caused injury or harm. These often target manufacturers of drugs, medical devices, vehicles, or consumer goods, and are frequently grouped into mass-tort or multidistrict litigation when many people are affected by the same product.
What type of case is this?
It is classified as “Product Liability” under the federal nature-of-suit system. Product liability lawsuits claim that a defective or dangerous product caused injury or harm. These often target manufacturers of drugs, medical devices, vehicles, or consumer goods, and are frequently grouped into mass-tort or multidistrict litigation when many people are affected by the same product.
What court is the case in?
The case is in the District Court, D. New Jersey, docket number 3:17-cv-01189.
When was the case filed?
Stapleton v. Janssen Pharmaceuticals, Inc was filed on 02/21/2017. It was terminated on 08/24/2020.
Other Cases Involving These Parties
Related Product Liability Cases
Source: public U.S. federal court record — docket 13456060 in the CourtListener/RECAP archive (verify this docket), court docket number 3:17-cv-01189 on PACER. Court, party, date and judge fields are reproduced from that record; case-type categories, statute decoding and all aggregate figures are derived by Docket Nexus (methodology).